Self-assembly nanomicelles based on cationic mPEG-PLA-b-Polyarginine(R15) triblock copolymer for siRNA delivery

Biomaterials - Tập 33 - Trang 6793-6807 - 2012
Zhi-Xia Zhao1, Shan-Yun Gao1, Jian-Cheng Wang1, Cheng-Jun Chen1, En-Yu Zhao1, Wen-Jie Hou1, Qiang Feng1, Ling-Yan Gao1, Xiao-Yan Liu1, Liang-Ren Zhang1, Qiang Zhang1
1State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, PR China

Tài liệu tham khảo

Fire, 2007, Gene silencing by double-stranded RNA (Nobel Lecture), Angew Chem Int Ed Engl, 46, 6966, 10.1002/anie.200701979 Kim, 2007, Strategies for silencing human disease using RNA interference, Nat Rev Genet, 8, 173, 10.1038/nrg2006 Jana, 2004, RNA interference: potential therapeutic targets, Appl Microbiol Biotechnol, 65, 649, 10.1007/s00253-004-1732-1 Zhang, 2007, Therapeutic potential of RNA interference against cellular targets of HIV infection, Mol Biotechnol, 37, 225, 10.1007/s12033-007-9000-0 Davis, 2011, Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles, Nature, 464, 1067, 10.1038/nature08956 Li, 2008, Efficient oncogene silencing and metastasis inhibition via systemic delivery of siRNA, Mol Ther, 16, 942, 10.1038/mt.2008.51 Song, 2005, Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors, Nat Biotechnol, 23, 709, 10.1038/nbt1101 Aliabadi, 2012, Supramolecular assemblies in functional siRNA delivery: where do we stand?, Biomaterials, 33, 2546, 10.1016/j.biomaterials.2011.11.079 Guo, 2011, Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?, Biotechnol Adv, 29, 402, 10.1016/j.biotechadv.2011.03.003 Kim, 2009, Strategies for targeted nonviral delivery of siRNAs in vivo, Trends Mol Med, 15, 491, 10.1016/j.molmed.2009.09.001 de Martimprey, 2009, Polymer nanocarriers for the delivery of small fragments of nucleic acids: oligonucleotides and siRNA, Eur J Pharm Biopharm, 71, 490, 10.1016/j.ejpb.2008.09.024 Patil, 2009, Polymeric nanoparticles for siRNA delivery and gene silencing, Int J Pharm, 367, 195, 10.1016/j.ijpharm.2008.09.039 Hwa Kim, 2005, Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine), J Control Release, 104, 223, 10.1016/j.jconrel.2005.02.006 Sato, 2007, Polymer brush-stabilized polyplex for a siRNA carrier with long circulatory half-life, J Control Release, 122, 209, 10.1016/j.jconrel.2007.04.018 Moghimi, 2005, A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy, Mol Ther, 11, 990, 10.1016/j.ymthe.2005.02.010 Symonds, 2005, Low and high molecular weight poly(L-lysine)s/poly(L-lysine)-DNA complexes initiate mitochondrial-mediated apoptosis differently, FEBS Lett, 579, 6191, 10.1016/j.febslet.2005.09.092 Wightman, 2001, Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo, J Gene Med, 3, 362, 10.1002/jgm.187 Sahoo, 2002, Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake, J Control Release, 82, 105, 10.1016/S0168-3659(02)00127-X Kim, 2005, Physicochemical characterization of poly(L-lactic acid) and poly(D, L-lactide-co-glycolide) nanoparticles with polyethylenimine as gene delivery carrier, Int J Pharm, 298, 255, 10.1016/j.ijpharm.2005.04.017 Wang, 2011, Materializing sequential killing of tumor vasculature and tumor cells via targeted polymeric micelle system, J Control Release, 149, 299, 10.1016/j.jconrel.2010.10.027 Mu, 2010, The effects of mixed MPEG-PLA/Pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxel, Biomaterials, 31, 2371, 10.1016/j.biomaterials.2009.11.102 Zheng, 2010, Preparation of MPEG-PLA nanoparticle for honokiol delivery in vitro, Int J Pharm, 386, 262, 10.1016/j.ijpharm.2009.11.014 Liu, 2012, A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery, Biomaterials, 33, 4403, 10.1016/j.biomaterials.2012.02.041 Futaki, 2005, Membrane-permeable arginine-rich peptides and the translocation mechanisms, Adv Drug Deliv Rev, 57, 547, 10.1016/j.addr.2004.10.009 Kim, 2010, RNA interference in vitro and in vivo using an arginine peptide/siRNA complex system, J Control Release, 143, 335, 10.1016/j.jconrel.2010.01.009 Kim, 2007, Arginine-conjugated polypropylenimine dendrimer as a non-toxic and efficient gene delivery carrier, Biomaterials, 28, 2061, 10.1016/j.biomaterials.2006.12.013 Veiseh, 2011, Cell transcytosing poly-arginine coated magnetic nanovector for safe and effective siRNA delivery, Biomaterials, 32, 5717, 10.1016/j.biomaterials.2011.04.039 Won, 2011, Poly(oligo-D-arginine) with internal disulfide linkages as a cytoplasm-sensitive carrier for siRNA delivery, Mol Ther, 19, 372, 10.1038/mt.2010.242 Kim, 2009, Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems, Biomaterials, 30, 658, 10.1016/j.biomaterials.2008.10.009 Wang, 2007, Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and pluronic-mediated overcoming multidrug resistance in tumor cell lines, Int J Pharm, 337, 63, 10.1016/j.ijpharm.2006.12.033 Yoo, 1999, Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release, Pharm Res, 16, 1114, 10.1023/A:1018908421434 Salmaso, 2009, Targeting glioma cells in vitro with ascorbate-conjugated pharmaceutical nanocarriers, Bioconjug Chem, 20, 2348, 10.1021/bc900369d Wang, 2008, Self-assembled micelles of biodegradable triblock copolymers based on poly(ethyl ethylene phosphate) and poly(-caprolactone) as drug carriers, Biomacromolecules, 9, 388, 10.1021/bm700732g Vichai, 2006, Sulforhodamine B colorimetric assay for cytotoxicity screening, Nat Protoc, 1, 1112, 10.1038/nprot.2006.179 Jiang, 2010, Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin, Eur J Pharm Biopharm, 76, 170, 10.1016/j.ejpb.2010.06.011 Li, 2008, Tumor-targeted delivery of siRNA by self-assembled nanoparticles, Mol Ther, 16, 163, 10.1038/sj.mt.6300323 Sun, 2008, Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery, Biomaterials, 29, 4348, 10.1016/j.biomaterials.2008.07.036 Fischer, 2003, In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis, Biomaterials, 24, 1121, 10.1016/S0142-9612(02)00445-3 Weber, 2012, PEGylated poly(ethylene imine) copolymer-delivered siRNA inhibits HIV replication in vitro, J Control Release, 157, 55, 10.1016/j.jconrel.2011.09.059 Khalil, 2006, Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery, Pharmacol Rev, 58, 32, 10.1124/pr.58.1.8 Hossain, 2010, Carbonate apatite-facilitated intracellularly delivered siRNA for efficient knockdown of functional genes, J Control Release, 147, 101, 10.1016/j.jconrel.2010.06.024 Varkouhi, 2011, Endosomal escape pathways for delivery of biologicals, J Control Release, 151, 220, 10.1016/j.jconrel.2010.11.004 Kim, 2011, Bioreducible polymers with cell penetrating and endosome buffering functionality for gene delivery systems, J Control Release, 152, 110, 10.1016/j.jconrel.2011.02.013 Ciardiello, 2003, Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs, Eur J Cancer, 39, 1348, 10.1016/S0959-8049(03)00235-1 Judge, 2005, Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA, Nat Biotechnol, 23, 457, 10.1038/nbt1081 Sledz, 2003, Activation of the interferon system by short-interfering RNAs, Nat Cell Biol, 5, 834, 10.1038/ncb1038 Kariko, 2004, Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3, J Immunol, 172, 6545, 10.4049/jimmunol.172.11.6545 Gao, 2011, The promotion of siRNA delivery to breast cancer overexpressing epidermal growth factor receptor through anti-EGFR antibody conjugation by immunoliposomes, Biomaterials, 32, 3459, 10.1016/j.biomaterials.2011.01.034